MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized by the accumulation of extracellular beta-amyloid (Aβ) proteins, which affects subsequent events that include tau deposition, synaptic and neuronal loss, and cognitive decline [1, 2].